An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. (Q51932203)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2007
edit
Language Label Description Also known as
English
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations.
scientific article published in May 2007

    Statements

    An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit